If you’ve been eyeing Cognizant Technology Solutions (CTSH) lately, you probably heard the buzz about their latest Guinness World Records™ title. The company just hosted the largest online generative AI hackathon ever, drawing in more than 53,000 participants from 40 countries. For investors, this is more than just a fun footnote. It signals a strategic commitment to AI innovation and a significant investment in upskilling their workforce as part of a $1 billion digital initiative.

This global hackathon builds on several positive signals from Cognizant this year, including stable EBIT margins and steady revenue growth. Yet, despite these efforts and insider confidence, the stock’s price has drifted down about 5% over the year, while three-year total returns stand at 18% and revenue continues to climb. Momentum has slowed since the spring, but long-term performance and ongoing transformation initiatives may be establishing a new foundation for future growth.

After this wave of news and a dip in the stock price, is the market being overly cautious, or is Cognizant fairly valued for what’s coming next?

Most Popular Narrative: 17% Undervalued

According to community narrative, Cognizant’s current share price is trading well below its estimated fair value. Analysts see significant upside potential based on medium-term growth in AI consulting, automation, and profit margin improvement.

Client transition from experimentation to large-scale implementation of GenAI and automation projects is fueling a new wave of large, multi-year deal wins. This trend is especially notable in Financial Services and Health Sciences, indicating stronger long-term recurring revenue visibility and potential for sustained double-digit EPS growth.

Curious about what’s fueling this bullish call? The narrative points to ambitious growth projections and a profit engine that could surprise many on Wall Street. Wondering which key assumptions and margin improvements are behind this double-digit upside? Continue reading to see the numbers and catalysts analysts believe could lift Cognizant well above its current valuation.

Result: Fair Value of $87.63 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, heightened competition from tech giants or clients rapidly automating tasks could put pressure on Cognizant’s margins and present challenges to its traditional growth path.

Find out about the key risks to this Cognizant Technology Solutions narrative.

Another View: Discounted Cash Flow Model

Taking a step back from analyst targets, our DCF model also suggests the current share price is below fair value. While both methods point in the same direction, the question remains: will cash flow assumptions hold up if the market shifts?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Cognizant Technology Solutions for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Cognizant Technology Solutions Narrative

If you see things differently or want to dig deeper into the numbers, it’s easy to put your own story together in just a few minutes. Feel free to do it your way.

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Cognizant Technology Solutions.

Looking for More Investment Ideas?

Momentum is built by acting on timely opportunities. Want an edge in today’s market? Don’t let these unique themes slip by. Expand your portfolio now with these smart stock ideas that many overlook:

• Capture stable income and peace of mind when you target companies offering robust yields above 3% through the dividend stocks that power steady returns: dividend stocks with yields > 3%.
• Accelerate your gains by seeking out undervalued stocks based on real cash flow performance, helping you spot hidden gems the market has missed with: undervalued stocks based on cash flows.
• Tap into the healthcare revolution by investing in fast-growing firms at the crossroads of medicine and artificial intelligence. Discover emerging leaders in healthcare AI: healthcare AI stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.